{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:35Z","timestamp":1707525635140},"reference-count":116,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,16]]},"DOI":"10.7759\/cureus.52397","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T21:07:17Z","timestamp":1705439237000},"source":"Crossref","is-referenced-by-count":0,"title":["Randomized Clinical Trials in Cerebrovascular Neurosurgery From 2018 to 2022"],"prefix":"10.7759","author":[{"given":"Ari D","family":"Kappel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary B","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai U","family":"Frerichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirav J","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A","family":"Aziz-Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.10.001","article-title":"2016-2017 clinical trials in cerebrovascular neurosurgery","volume":"60","author":"Huang W","year":"2019","unstructured":"Huang W, Du R. 2016-2017 clinical trials in cerebrovascular neurosurgery. J Clin Neurosci. 2019, 60:31-5. 10.1016\/j.jocn.2018.10.001","journal-title":"J Clin Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer OA","year":"2015","unstructured":"Berkhemer OA, Fransen PS, Beumer D, et al.. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015, 372:11-20. 10.1056\/NEJMoa1411587","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell BC","year":"2015","unstructured":"Campbell BC, Mitchell PJ, Kleinig TJ, et al.. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015, 372:1009-18. 10.1056\/NEJMoa1414792","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal M","year":"2015","unstructured":"Goyal M, Demchuk AM, Menon BK, et al.. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015, 372:1019-30. 10.1056\/NEJMoa1414905","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503780","article-title":"Thrombectomy within 8 hours after symptom onset in ischemic stroke","volume":"372","author":"Jovin TG","year":"2015","unstructured":"Jovin TG, Chamorro A, Cobo E, et al.. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015, 372:2296-306. 10.1056\/NEJMoa1503780","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver JL","year":"2015","unstructured":"Saver JL, Goyal M, Bonafe A, et al.. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015, 372:2285-95. 10.1056\/NEJMoa1415061","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30177-6","article-title":"Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial","volume":"15","author":"Bracard S","year":"2016","unstructured":"Bracard S, Ducrocq X, Mas JL, et al.. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016, 15:1138-47. 10.1016\/S1474-4422(16)30177-6","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira RG","year":"2018","unstructured":"Nogueira RG, Jadhav AP, Haussen DC, et al.. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018, 378:11-21. 10.1056\/NEJMoa1706442","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging","volume":"378","author":"Albers GW","year":"2018","unstructured":"Albers GW, Marks MP, Kemp S, et al.. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018, 378:708-18. 10.1056\/NEJMoa1713973","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2000120","article-title":"Thrombectomy for stroke in the public health care system of Brazil","volume":"382","author":"Martins SO","year":"2020","unstructured":"Martins SO, Mont'Alverne F, Rebello LC, et al.. Thrombectomy for stroke in the public health care system of Brazil. N Engl J Med. 2020, 382:2316-26. 10.1056\/NEJMoa2000120","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular therapy for acute stroke with a large ischemic region","volume":"386","author":"Yoshimura S","year":"2022","unstructured":"Yoshimura S, Sakai N, Yamagami H, et al.. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med. 2022, 386:1303-13. 10.1056\/NEJMoa2118191","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213379","article-title":"Trial of endovascular therapy for acute ischemic stroke with large infarct","volume":"388","author":"Huo X","year":"2023","unstructured":"Huo X, Ma G, Tong X, et al.. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med. 2023, 388:1272-83. 10.1056\/NEJMoa2213379","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214403","article-title":"Trial of endovascular thrombectomy for large ischemic strokes","volume":"388","author":"Sarraj A","year":"2023","unstructured":"Sarraj A, Hassan AE, Abraham MG, et al.. Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med. 2023, 388:1259-71. 10.1056\/NEJMoa2214403","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.2385","article-title":"Direct to angiography suite without stopping for computed tomography imaging for patients with acute stroke: a randomized clinical trial","volume":"78","author":"Requena M","year":"2021","unstructured":"Requena M, Oliv\u00e9-Gadea M, Muchada M, et al.. Direct to angiography suite without stopping for computed tomography imaging for patients with acute stroke: a randomized clinical trial. JAMA Neurol. 2021, 78:1099-107. 10.1001\/jamaneurol.2021.2385","journal-title":"JAMA Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3967","article-title":"Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial","volume":"75","author":"Nogueira RG","year":"2018","unstructured":"Nogueira RG, Frei D, Kirmani JF, et al.. Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial. JAMA Neurol. 2018, 75:304-11. 10.1001\/jamaneurol.2017.3967","journal-title":"JAMA Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13827","article-title":"Effect of thrombectomy with combined contact aspiration and stent retriever vs stent retriever alone on Revascularization in patients with acute ischemic stroke and large vessel occlusion: the Aster2 randomized clinical trial","volume":"326","author":"Lapergue B","year":"2021","unstructured":"Lapergue B, Blanc R, Costalat V, et al.. Effect of thrombectomy with combined contact aspiration and stent retriever vs stent retriever alone on Revascularization in patients with acute ischemic stroke and large vessel occlusion: the Aster2 randomized clinical trial. JAMA. 2021, 326:1158-69. 10.1001\/jama.2021.13827","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.9644","article-title":"Effect of endovascular contact aspiration vs stent retriever on Revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial","volume":"318","author":"Lapergue B","year":"2017","unstructured":"Lapergue B, Blanc R, Gory B, et al.. Effect of endovascular contact aspiration vs stent retriever on Revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA. 2017, 318:443-52. 10.1001\/jama.2017.9644","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30297-1","article-title":"Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial","volume":"393","author":"Turk AS","year":"2019","unstructured":"Turk AS, Siddiqui A, Fifi JT, et al.. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019, 393:998-1008. 10.1016\/S0140-6736(19)30297-1","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2017-013722","article-title":"A comparison of direct aspiration versus stent retriever as a first approach ('COMPASS'): protocol","volume":"10","author":"Turk AS","year":"2018","unstructured":"Turk AS, Siddiqui AH, Mocco J. A comparison of direct aspiration versus stent retriever as a first approach ('COMPASS'): protocol. J Neurointerv Surg. 2018, 10:953-7. 10.1136\/neurintsurg-2017-013722","journal-title":"J Neurointerv Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6074","article-title":"First-line Sofia aspiration thrombectomy approach within the endovascular treatment of ischemic stroke multicentric registry: efficacy, safety, and predictive factors of success","volume":"40","author":"Marnat G","year":"2019","unstructured":"Marnat G, Barreau X, Detraz L, et al.. First-line Sofia aspiration thrombectomy approach within the endovascular treatment of ischemic stroke multicentric registry: efficacy, safety, and predictive factors of success. AJNR Am J Neuroradiol. 2019, 40:1006-12. 10.3174\/ajnr.A6074","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3171\/2020.3.JNS193356","article-title":"RECO flow restoration device versus solitaire FR with the intention for thrombectomy study (REDIRECT): a prospective randomized controlled trial","volume":"134","author":"Cao J","year":"2020","unstructured":"Cao J, Lin H, Lin M, et al.. RECO flow restoration device versus solitaire FR with the intention for thrombectomy study (REDIRECT): a prospective randomized controlled trial. J Neurosurg. 2020, 134:1569-77. 10.3171\/2020.3.JNS193356","journal-title":"J Neurosurg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.686253","article-title":"Efficacy and safety of a novel thrombectomy device in patients with acute ischemic stroke: a randomized controlled trial","volume":"12","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Hua W, Li Z, et al.. Efficacy and safety of a novel thrombectomy device in patients with acute ischemic stroke: a randomized controlled trial. Front Neurol. 2021, 12:686253. 10.3389\/fneur.2021.686253","journal-title":"Front Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034436","article-title":"New class of radially adjustable stentrievers for acute ischemic stroke: primary results of the multicenter Tiger trial","volume":"52","author":"Gupta R","year":"2021","unstructured":"Gupta R, Saver JL, Levy E, et al.. New class of radially adjustable stentrievers for acute ischemic stroke: primary results of the multicenter Tiger trial. Stroke. 2021, 52:1534-44. 10.1161\/STROKEAHA.121.034436","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30395-3","article-title":"Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial","volume":"1016","author":"Liu X","year":"2020","unstructured":"Liu X, Dai Q, Ye R, et al.. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020, 1016:1474-4422. 10.1016\/S1474-4422(19)30395-3","journal-title":"Lancet Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206317","article-title":"Trial of endovascular treatment of acute basilar-artery occlusion","volume":"387","author":"Tao C","year":"2022","unstructured":"Tao C, Nogueira RG, Zhu Y, et al.. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med. 2022, 387:1361-72. 10.1056\/NEJMoa2206317","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207576","article-title":"Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion","volume":"387","author":"Jovin TG","year":"2022","unstructured":"Jovin TG, Li C, Wu L, et al.. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med. 2022, 387:1373-84. 10.1056\/NEJMoa2207576","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.4474","article-title":"Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke a randomized clinical trial","volume":"75","author":"Simonsen CZ","year":"2018","unstructured":"Simonsen CZ, Yoo AJ, S\u00f8rensen LH, Juul N, Johnsen SP, Andersen G, Rasmussen M. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke a randomized clinical trial. JAMA Neurol. 2018, 75:470-7. 10.1001\/jamaneurol.2017.4474","journal-title":"JAMA Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke","volume":"382","author":"Yang P","year":"2020","unstructured":"Yang P, Zhang Y, Zhang L, et al.. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med. 2020, 382:1981-93. 10.1056\/NEJMoa2001123","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107727","article-title":"A randomized trial of intravenous alteplase before endovascular treatment for stroke","volume":"385","author":"LeCouffe NE","year":"2021","unstructured":"LeCouffe NE, Kappelhof M, Treurniet KM, et al.. A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med. 2021, 385:1833-44. 10.1056\/NEJMoa2107727","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.23523","article-title":"Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial","volume":"325","author":"Zi W","year":"2021","unstructured":"Zi W, Qiu Z, Li F, et al.. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA. 2021, 325:234-43. 10.1001\/jama.2020.23523","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.23522","article-title":"Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial","volume":"325","author":"Suzuki K","year":"2021","unstructured":"Suzuki K, Matsumaru Y, Takeuchi M, et al.. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial. JAMA. 2021, 325:244-53. 10.1001\/jama.2020.23522","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00537-2","article-title":"Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial","volume":"400","author":"Fischer U","year":"2022","unstructured":"Fischer U, Kaesmacher J, Strbian D, et al.. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022, 400:104-15. 10.1016\/S0140-6736(22)00537-2","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1645","article-title":"Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial","volume":"327","author":"Ren\u00fa A","year":"2022","unstructured":"Ren\u00fa A, Mill\u00e1n M, San Rom\u00e1n L, et al.. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial. JAMA. 2022, 327:826-35. 10.1001\/jama.2022.1645","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2021.03475","article-title":"Direct-safe: A randomized controlled trial of DIRECT endovascular clot retrieval versus standard bridging therapy","volume":"24","author":"Mitchell PJ","year":"2022","unstructured":"Mitchell PJ, Yan B, Churilov L, et al.. Direct-safe: A randomized controlled trial of DIRECT endovascular clot retrieval versus standard bridging therapy. J Stroke. 2022, 24:57-64. 10.5853\/jos.2021.03475","journal-title":"J Stroke"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019840938","article-title":"Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection","volume":"14","author":"Ringleb P","year":"2019","unstructured":"Ringleb P, Bendszus M, Bluhmki E, et al.. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection. Int J Stroke. 2019, 14:483-90. 10.1177\/1747493019840938","journal-title":"Int J Stroke"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset","volume":"379","author":"Thomalla G","year":"2018","unstructured":"Thomalla G, Simonsen CZ, Boutitie F, et al.. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018, 379:611-22. 10.1056\/NEJMoa1804355","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke","volume":"380","author":"Ma H","year":"2019","unstructured":"Ma H, Campbell BC, Parsons MW, et al.. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019, 380:1795-803. 10.1056\/NEJMoa1813046","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.028127","article-title":"Thrombolysis with alteplase at 0.6 mg\/kg for stroke with unknown time of onset: a randomized controlled trial","volume":"51","author":"Koga M","year":"2020","unstructured":"Koga M, Yamamoto H, Inoue M, et al.. Thrombolysis with alteplase at 0.6 mg\/kg for stroke with unknown time of onset: a randomized controlled trial. Stroke. 2020, 51:1530-8. 10.1161\/STROKEAHA.119.028127","journal-title":"Stroke"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00124-7","article-title":"Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial","volume":"21","author":"Kvistad CE","year":"2022","unstructured":"Kvistad CE, N\u00e6ss H, Helleberg BH, et al.. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. Lancet Neurol. 2022, 21:511-9. 10.1016\/S1474-4422(22)00124-7","journal-title":"Lancet Neurol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial","volume":"16","author":"Logallo N","year":"2017","unstructured":"Logallo N, Novotny V, Assmus J, et al.. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017, 16:781-8. 10.1016\/S1474-4422(17)30253-3","journal-title":"Lancet Neurol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial","volume":"400","author":"Menon BK","year":"2022","unstructured":"Menon BK, Buck BH, Singh N, et al.. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022, 400:161-9. 10.1016\/S0140-6736(22)01054-6","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell BC","year":"2018","unstructured":"Campbell BC, Mitchell PJ, Churilov L, et al.. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018, 378:1573-82. 10.1056\/NEJMoa1716405","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1511","article-title":"Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial","volume":"323","author":"Campbell BC","year":"2020","unstructured":"Campbell BC, Mitchell PJ, Churilov L, et al.. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial. JAMA. 2020, 323:1257-65. 10.1001\/jama.2020.1511","journal-title":"JAMA"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00210-6","article-title":"Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4\u00b75 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial","volume":"20","author":"Gusev EI","year":"2021","unstructured":"Gusev EI, Martynov MY, Nikonov AA, et al.. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4\u00b75 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial. Lancet Neurol. 2021, 20:721-8. 10.1016\/S1474-4422(21)00210-6","journal-title":"Lancet Neurol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston SC","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, et al.. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018, 379:215-25. 10.1056\/NEJMoa1800410","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston SC","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H, et al.. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020, 383:207-17. 10.1056\/NEJMoa1916870","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.4396","article-title":"Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke: a randomized clinical trial","volume":"78","author":"Amarenco P","year":"2020","unstructured":"Amarenco P, Denison H, Evans SR, et al.. Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke: a randomized clinical trial. JAMA Neurol. 2020, 78:1-9. 10.1001\/jamaneurol.2020.4396","journal-title":"JAMA Neurol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial","volume":"391","author":"Bath PM","year":"2018","unstructured":"Bath PM, Woodhouse LJ, Appleton JP, et al.. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet. 2018, 391:850-9. 10.1016\/S0140-6736(17)32849-0","journal-title":"Lancet"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA","volume":"385","author":"Wang Y","year":"2021","unstructured":"Wang Y, Meng X, Wang A, et al.. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021, 385:2520-30. 10.1056\/NEJMoa2111749","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang Y","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, et al.. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013, 369:11-9. 10.1056\/NEJMoa1215340","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0247","article-title":"Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial","volume":"75","author":"Jing J","year":"2018","unstructured":"Jing J, Meng X, Zhao X, et al.. Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial. JAMA Neurol. 2018, 75:711-9. 10.1001\/jamaneurol.2018.0247","journal-title":"JAMA Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial","volume":"320","author":"Khatri P","year":"2018","unstructured":"Khatri P, Kleindorfer DO, Devlin T, et al.. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial. JAMA. 2018, 320:156-66. 10.1001\/jama.2018.8496","journal-title":"JAMA"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30038-8","article-title":"Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial","volume":"393","author":"Anderson CS","year":"2019","unstructured":"Anderson CS, Huang Y, Lindley RI, et al.. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet. 2019, 393:877-88. 10.1016\/S0140-6736(19)30038-8","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1177\/1747493020932784","article-title":"Controlling hypertension after severe cerebrovascular event (CHASE): a randomized, multicenter, controlled study","volume":"16","author":"Yuan F","year":"2021","unstructured":"Yuan F, Yang F, Zhao J, et al.. Controlling hypertension after severe cerebrovascular event (CHASE): a randomized, multicenter, controlled study. Int J Stroke. 2021, 16:456-65. 10.1177\/1747493020932784","journal-title":"Int J Stroke"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30483-X","article-title":"Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial","volume":"20","author":"Mazighi M","year":"2021","unstructured":"Mazighi M, Richard S, Lapergue B, et al.. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2021, 20:265-74. 10.1016\/S1474-4422(20)30483-X","journal-title":"Lancet Neurol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1177\/23969873211000879","article-title":"Individualized blood pressure management during endovascular treatment of acute ischemic stroke under procedural sedation (INDIVIDUATE) - an explorative randomized controlled trial","volume":"6","author":"Chen M","year":"2021","unstructured":"Chen M, Kronsteiner D, M\u00f6hlenbruch MA, et al.. Individualized blood pressure management during endovascular treatment of acute ischemic stroke under procedural sedation (INDIVIDUATE) - an explorative randomized controlled trial. Eur Stroke J. 2021, 6:276-82. 10.1177\/23969873211000879","journal-title":"Eur Stroke J"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4404","article-title":"Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas: the RACECAT randomized clinical trial","volume":"327","author":"P\u00e9rez de la Ossa N","year":"2022","unstructured":"P\u00e9rez de la Ossa N, Abilleira S, Jovin TG, et al.. Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas: the RACECAT randomized clinical trial. JAMA. 2022, 327:1782-94. 10.1001\/jama.2022.4404","journal-title":"JAMA"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2829","article-title":"Prehospital stroke management optimized by use of clinical scoring vs mobile stroke unit for triage of patients with stroke: a randomized clinical trial","volume":"76","author":"Helwig SA","year":"2019","unstructured":"Helwig SA, Ragoschke-Schumm A, Schwindling L, et al.. Prehospital stroke management optimized by use of clinical scoring vs mobile stroke unit for triage of patients with stroke: a randomized clinical trial. JAMA Neurol. 2019, 76:1484-92. 10.1001\/jamaneurol.2019.2829","journal-title":"JAMA Neurol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30194-1","article-title":"Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial","volume":"393","year":"2019","unstructured":"Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2). an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet. 2019, 393:1009-20. 10.1016\/S0140-6736(19)30194-1","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7268924","article-title":"Efficacy of high-dose and low-dose simvastatin on vascular oxidative stress and neurological outcomes in patient with acute ischemic stroke: a randomized, double-blind, parallel, controlled trial","volume":"2018","author":"Uransilp N","year":"2018","unstructured":"Uransilp N, Chaiyawatthanananthn P, Muengtaweepongsa S. Efficacy of high-dose and low-dose simvastatin on vascular oxidative stress and neurological outcomes in patient with acute ischemic stroke: a randomized, double-blind, parallel, controlled trial. Neurol Res Int. 2018, 2018:7268924. 10.1155\/2018\/7268924","journal-title":"Neurol Res Int"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9346","article-title":"Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial","volume":"322","author":"Johnston KC","year":"2019","unstructured":"Johnston KC, Bruno A, Pauls Q, et al.. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019, 322:326-35. 10.1001\/jama.2019.9346","journal-title":"JAMA"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30026-2","article-title":"Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial","volume":"18","author":"Alexandrov A V.","year":"2019","unstructured":"Alexandrov A V., K\u00f6hrmann M, Soinne L, et al.. Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial. Lancet Neurol. 2019, 18:338-47. 10.1016\/S1474-4422(19)30026-2","journal-title":"Lancet Neurol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.024582","article-title":"Sphenopalatine ganglion stimulation to augment cerebral blood flow: a randomized, sham-controlled trial","volume":"50","author":"Bornstein NM","year":"2019","unstructured":"Bornstein NM, Saver JL, Diener HC, et al.. Sphenopalatine ganglion stimulation to augment cerebral blood flow: a randomized, sham-controlled trial. Stroke. 2019, 50:2108-17. 10.1161\/STROKEAHA.118.024582","journal-title":"Stroke"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31192-4","article-title":"An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT- 24B): an international, randomised, double-blind, sham-controlled, pivotal trial","volume":"394","author":"Bornstein NM","year":"2019","unstructured":"Bornstein NM, Saver JL, Diener HC, et al.. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT- 24B): an international, randomised, double-blind, sham-controlled, pivotal trial. Lancet. 2019, 394:219-29. 10.1016\/S0140-6736(19)31192-4","journal-title":"Lancet"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill MD","year":"2020","unstructured":"Hill MD, Goyal M, Menon BK, et al.. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020, 395:878-87. 10.1016\/S0140-6736(20)30258-0","journal-title":"Lancet"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2019.05.008","article-title":"A randomized trial of endovascular versus surgical management of ruptured intracranial aneurysms: Interim results from ISAT2","volume":"65","author":"Darsaut TE","year":"2019","unstructured":"Darsaut TE, Roy D, Weill A, et al.. A randomized trial of endovascular versus surgical management of ruptured intracranial aneurysms: Interim results from ISAT2. Neurochirurgie. 2019, 65:370-6. 10.1016\/j.neuchi.2019.05.008","journal-title":"Neurochirurgie"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3171\/2011.8.JNS101767","article-title":"The Barrow ruptured aneurysm trial","volume":"116","author":"McDougall CG","year":"2012","unstructured":"McDougall CG, Spetzler RF, Zabramski JM, Partovi S, Hills NK, Nakaji P, Albuquerque FC. The Barrow ruptured aneurysm trial. J Neurosurg. 2012, 116:135-44. 10.3171\/2011.8.JNS101767","journal-title":"J Neurosurg"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3171\/2016.9.JNS161301","article-title":"Analysis of saccular aneurysms in the Barrow ruptured aneurysm trial","volume":"128","author":"Spetzler RF","year":"2018","unstructured":"Spetzler RF, Zabramski JM, McDougall CG, Albuquerque FC, Hills NK, Wallace RC, Nakaji P. Analysis of saccular aneurysms in the Barrow ruptured aneurysm trial. J Neurosurg. 2018, 128:120-5. 10.3171\/2016.9.JNS161301","journal-title":"J Neurosurg"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3171\/2018.8.JNS181846","article-title":"Ten-year analysis of saccular aneurysms in the Barrow ruptured aneurysm trial","volume":"132","author":"Spetzler RF","year":"2019","unstructured":"Spetzler RF, McDougall CG, Zabramski JM, et al.. Ten-year analysis of saccular aneurysms in the Barrow ruptured aneurysm trial. J Neurosurg. 2019, 132:771-6. 10.3171\/2018.8.JNS181846","journal-title":"J Neurosurg"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2021.12.083","article-title":"Middle cerebral artery aneurysm trial (MCAAT): a randomized care trial comparing surgical and endovascular management of MCA aneurysm patients","volume":"160","author":"Darsaut TE","year":"2022","unstructured":"Darsaut TE, Keough MB, Boisseau W, et al.. Middle cerebral artery aneurysm trial (MCAAT): a randomized care trial comparing surgical and endovascular management of MCA aneurysm patients. World Neurosurg. 2022, 160:e49-54. 10.1016\/j.wneu.2021.12.083","journal-title":"World Neurosurg"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105171","article-title":"Seizure prophylaxis in unruptured aneurysm repair: a randomized controlled trial","volume":"29","author":"Daou BJ","year":"2020","unstructured":"Daou BJ, Maher CO, Holste K, et al.. Seizure prophylaxis in unruptured aneurysm repair: a randomized controlled trial. J Stroke Cerebrovasc Dis. 2020, 29:105171. 10.1016\/j.jstrokecerebrovasdis.2020.105171","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5619","article-title":"Parent artery reconstruction for large or giant cerebral aneurysms using the tubridge flow diverter: A multicenter, randomized, controlled clinical trial (PARAT)","volume":"39","author":"Liu JM","year":"2018","unstructured":"Liu JM, Zhou Y, Li Y, et al.. Parent artery reconstruction for large or giant cerebral aneurysms using the tubridge flow diverter: A multicenter, randomized, controlled clinical trial (PARAT). AJNR Am J Neuroradiol. 2018, 39:807-16. 10.3174\/ajnr.A5619","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.018707","article-title":"Second-generation hydrogel coils for the endovascular treatment of intracranial aneurysms a randomized controlled trial","volume":"49","author":"Taschner CA","year":"2018","unstructured":"Taschner CA, Chapot R, Costalat V, et al.. Second-generation hydrogel coils for the endovascular treatment of intracranial aneurysms a randomized controlled trial. Stroke. 2018, 49:667-74. 10.1161\/STROKEAHA.117.018707","journal-title":"Stroke"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa006","article-title":"The hydrogel endovascular aneurysm treatment trial (HEAT): a randomized controlled trial of the second-generation hydrogel coil","volume":"86","author":"Bendok BR","year":"2020","unstructured":"Bendok BR, Abi-Aad KR, Ward JD, et al.. The hydrogel endovascular aneurysm treatment trial (HEAT): a randomized controlled trial of the second-generation hydrogel coil. Neurosurgery. 2020, 86:615-24. 10.1093\/neuros\/nyaa006","journal-title":"Neurosurgery"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2019-014815","article-title":"The safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms: final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study","volume":"11","author":"Arthur AS","year":"2019","unstructured":"Arthur AS, Molyneux A, Coon AL, et al.. The safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms: final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study. J Neurointerv Surg. 2019, 11:924-30. 10.1136\/neurintsurg-2019-014815","journal-title":"J Neurointerv Surg"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00737","article-title":"TARGET\u00ae intracranial aneurysm coiling prospective multicenter registry: Final analysis of peri-procedural and long-term safety and efficacy results","volume":"10","author":"Zaidat OO","year":"2019","unstructured":"Zaidat OO, Castonguay AC, Rai AT, et al.. TARGET\u00ae intracranial aneurysm coiling prospective multicenter registry: Final analysis of peri-procedural and long-term safety and efficacy results. Front Neurol. 2019, 10:737. 10.3389\/fneur.2019.00737","journal-title":"Front Neurol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018189","article-title":"Treatment of large and giant posterior communicating artery aneurysms with the surpass streamline flow diverter: results from the SCENT trial","volume":"15","author":"Kan P","year":"2023","unstructured":"Kan P, Mohanty A, Meyers PM, et al.. Treatment of large and giant posterior communicating artery aneurysms with the surpass streamline flow diverter: results from the SCENT trial. J Neurointerv Surg. 2023, 15:679-83. 10.1136\/neurintsurg-2021-018189","journal-title":"J Neurointerv Surg"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0000000000001783","article-title":"The safety and effectiveness of the contour neurovascular system (contour) for the treatment of bifurcation aneurysms: the CERUS study","volume":"90","author":"Liebig T","year":"2022","unstructured":"Liebig T, Killer-Oberpfalzer M, Gal G, et al.. The safety and effectiveness of the contour neurovascular system (contour) for the treatment of bifurcation aneurysms: the CERUS study. Neurosurgery. 2022, 90:270-7. 10.1227\/NEU.0000000000001783","journal-title":"Neurosurgery"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-017469","article-title":"Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial","volume":"14","author":"McDougall CG","year":"2022","unstructured":"McDougall CG, Diaz O, Boulos A, et al.. Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial. J Neurointerv Surg. 2022, 14:577-84. 10.1136\/neurintsurg-2021-017469","journal-title":"J Neurointerv Surg"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3857","article-title":"Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial","volume":"35","author":"McDougall CG","year":"2014","unstructured":"McDougall CG, Johnston SC, Gholkar A, et al.. Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial. AJNR Am J Neuroradiol. 2014, 35:935-42. 10.3174\/ajnr.A3857","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016906","article-title":"Five-year results of randomized bioactive versus bare metal coils in the treatment of intracranial aneurysms: the Matrix and Platinum Science (MAPS) Trial","volume":"13","author":"McDougall CG","year":"2021","unstructured":"McDougall CG, Johnston SC, Hetts SW, et al.. Five-year results of randomized bioactive versus bare metal coils in the treatment of intracranial aneurysms: the Matrix and Platinum Science (MAPS) Trial. J Neurointerv Surg. 2021, 13:930-4. 10.1136\/neurintsurg-2020-016906","journal-title":"J Neurointerv Surg"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018414","article-title":"Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up","volume":"15","author":"Pierot L","year":"2023","unstructured":"Pierot L, Szikora I, Barreau X, et al.. Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up. J Neurointerv Surg. 2023, 15:552-7. 10.1136\/neurintsurg-2021-018414","journal-title":"J Neurointerv Surg"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6362","article-title":"Does increasing packing density using larger caliber coils improve angiographic results of embolization of intracranial aneurysms at 1 year: a randomized trial","volume":"41","author":"Raymond J","year":"2020","unstructured":"Raymond J, Ghostine J, van Adel BA, et al.. Does increasing packing density using larger caliber coils improve angiographic results of embolization of intracranial aneurysms at 1 year: a randomized trial. AJNR Am J Neuroradiol. 2020, 41:29-34. 10.3174\/ajnr.A6362","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.637551","article-title":"The smart registry: Long-term results on the utility of the penumbra smart coil system for treatment of intracranial aneurysms and other malformations","volume":"12","author":"Spiotta AM","year":"2021","unstructured":"Spiotta AM, Park MS, Bellon RJ, et al.. The smart registry: Long-term results on the utility of the penumbra smart coil system for treatment of intracranial aneurysms and other malformations. Front Neurol. 2021, 12:637551. 10.3389\/fneur.2021.637551","journal-title":"Front Neurol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-015947","article-title":"Deep neuromuscular block improves angiographic image quality during endovascular coiling of unruptured cerebral aneurysm: a randomized clinical trial","volume":"12","author":"Kim BY","year":"2020","unstructured":"Kim BY, Chung SH, Park SJ, Han SH, Kwon OK, Chung JY, Kim JH. Deep neuromuscular block improves angiographic image quality during endovascular coiling of unruptured cerebral aneurysm: a randomized clinical trial. J Neurointerv Surg. 2020, 12:1137-41. 10.1136\/neurintsurg-2020-015947","journal-title":"J Neurointerv Surg"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial","volume":"397","author":"Post R","year":"2021","unstructured":"Post R, Germans MR, Tjerkstra MA, et al.. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet. 2021, 397:112-8. 10.1016\/S0140-6736(20)32518-6","journal-title":"Lancet"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2018.11.004","article-title":"FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: a randomized controlled trial","volume":"65","author":"Gaberel T","year":"2019","unstructured":"Gaberel T, Gakuba C, Fournel F, et al.. FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Neurochirurgie. 2019, 65:14-9. 10.1016\/j.neuchi.2018.11.004","journal-title":"Neurochirurgie"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102788","article-title":"Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults","volume":"12","author":"Chen J","year":"2020","unstructured":"Chen J, Li M, Zhu X, et al.. Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults. Aging (Albany NY). 2020, 12:2939-51. 10.18632\/aging.102788","journal-title":"Aging (Albany NY)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17724682","article-title":"Long-acting statin for aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Naraoka M","year":"2018","unstructured":"Naraoka M, Matsuda N, Shimamura N, et al.. Long-acting statin for aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. J Cereb Blood Flow Metab. 2018, 38:1190-8. 10.1177\/0271678X17724682","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2018.1426207","article-title":"Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study","volume":"40","author":"Zhang C","year":"2018","unstructured":"Zhang C, Zhao S, Zang Y, et al.. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study. Neurol Res. 2018, 40:283-91. 10.1080\/01616412.2018.1426207","journal-title":"Neurol Res"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031260","article-title":"Intravenous hydrogen therapy with intracisternal magnesium sulfate infusion in severe aneurysmal subarachnoid hemorrhage","volume":"52","author":"Takeuchi S","year":"2021","unstructured":"Takeuchi S, Kumagai K, Toyooka T, Otani N, Wada K, Mori K. Intravenous hydrogen therapy with intracisternal magnesium sulfate infusion in severe aneurysmal subarachnoid hemorrhage. Stroke. 2021, 52:20-7. 10.1161\/STROKEAHA.120.031260","journal-title":"Stroke"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017956","article-title":"Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage a randomized clinical trial","volume":"49","author":"Gathier CS","year":"2018","unstructured":"Gathier CS, van den Bergh WM, van der Jagt M, et al.. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage a randomized clinical trial. Stroke. 2018, 49:76-83. 10.1161\/STROKEAHA.117.017956","journal-title":"Stroke"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.029279","article-title":"Impact of goal-directed therapy on delayed ischemia after aneurysmal subarachnoid hemorrhage: randomized controlled trial","volume":"51","author":"Anetsberger A","year":"2020","unstructured":"Anetsberger A, Gempt J, Blobner M, et al.. Impact of goal-directed therapy on delayed ischemia after aneurysmal subarachnoid hemorrhage: randomized controlled trial. Stroke. 2020, 51:2287-96. 10.1161\/STROKEAHA.120.029279","journal-title":"Stroke"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg N","year":"2018","unstructured":"Sprigg N, Flaherty K, Appleton JP, et al.. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018, 391:2107-15. 10.1016\/S0140-6736(18)31033-X","journal-title":"Lancet"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30195-3","article-title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial","volume":"393","author":"Hanley DF","year":"2019","unstructured":"Hanley DF, Thompson RE, Rosenblum M, et al.. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019, 393:1021-32. 10.1016\/S0140-6736(19)30195-3","journal-title":"Lancet"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2019.105656","article-title":"Fluoxetine for motor recovery after acute intracerebral hemorrhage, the FMRICH trial","volume":"190","author":"Marquez-Romero JM","year":"2020","unstructured":"Marquez-Romero JM, Reyes-Mart\u00ednez M, Huerta-Franco MR, Ruiz-Franco A, Silos H, Arauz A. Fluoxetine for motor recovery after acute intracerebral hemorrhage, the FMRICH trial. Clin Neurol Neurosurg. 2020, 190:105656. 10.1016\/j.clineuro.2019.105656","journal-title":"Clin Neurol Neurosurg"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04560-3","article-title":"Endoscopic intraventricular hematoma evacuation surgery versus external ventricular drainage for the treatment of patients with moderate to severe intraventricular hemorrhage: a multicenter, randomized, controlled trial","volume":"21","author":"Zhu J","year":"2020","unstructured":"Zhu J, Tang C, Cong Z, Yang J, Cai X, Liu Y, Ma C. Endoscopic intraventricular hematoma evacuation surgery versus external ventricular drainage for the treatment of patients with moderate to severe intraventricular hemorrhage: a multicenter, randomized, controlled trial. Trials. 2020, 21:640. 10.1186\/s13063-020-04560-3","journal-title":"Trials"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2943-6","article-title":"Safety and efficacy of applying sufficient analgesia combined with a minimal sedation program as an early antihypertensive treatment for spontaneous intracerebral hemorrhage: a randomized controlled trial","volume":"19","author":"Dong R","year":"2018","unstructured":"Dong R, Li F, Xu Y, Chen P, Maegele M, Yang H, Chen W. Safety and efficacy of applying sufficient analgesia combined with a minimal sedation program as an early antihypertensive treatment for spontaneous intracerebral hemorrhage: a randomized controlled trial. Trials. 2018, 19:607. 10.1186\/s13063-018-2943-6","journal-title":"Trials"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2019.08.095","article-title":"Prospective randomized placebo-controlled double-blind clinical study of adjuvant dexamethasone with surgery for chronic subdural haematoma with post-operative subdural drainage: interim analysis","volume":"71","author":"Mebberson K","year":"2020","unstructured":"Mebberson K, Colditz M, Marshman LA, Thomas PA, Mitchell PS, Robertson K. Prospective randomized placebo-controlled double-blind clinical study of adjuvant dexamethasone with surgery for chronic subdural haematoma with post-operative subdural drainage: interim analysis. J Clin Neurosci. 2020, 71:153-7. 10.1016\/j.jocn.2019.08.095","journal-title":"J Clin Neurosci"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020473","article-title":"Trial of dexamethasone for chronic subdural hematoma","volume":"383","author":"Hutchinson PJ","year":"2020","unstructured":"Hutchinson PJ, Edlmann E, Bulters D, et al.. Trial of dexamethasone for chronic subdural hematoma. N Engl J Med. 2020, 383:2616-27. 10.1056\/NEJMoa2020473","journal-title":"N Engl J Med"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2020.7560","article-title":"Corticosteroids as an adjuvant treatment to surgery in chronic subdural hematomas: a multi-center double-blind randomized placebo-controlled trial","volume":"38","author":"Ng S","year":"2021","unstructured":"Ng S, Boetto J, Huguet H, et al.. Corticosteroids as an adjuvant treatment to surgery in chronic subdural hematomas: a multi-center double-blind randomized placebo-controlled trial. J Neurotrauma. 2021, 38:1484-94. 10.1089\/neu.2020.7560","journal-title":"J Neurotrauma"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.2030","article-title":"Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial","volume":"75","author":"Jiang R","year":"2018","unstructured":"Jiang R, Zhao S, Wang R, et al.. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial. JAMA Neurol. 2018, 75:1338-46. 10.1001\/jamaneurol.2018.2030","journal-title":"JAMA Neurol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz095","article-title":"Subperiosteal vs subdural drain after burr-hole drainage of chronic subdural hematoma: a randomized clinical trial (cSDH-drain-trial)","volume":"85","author":"Soleman J","year":"2019","unstructured":"Soleman J, Lutz K, Schaedelin S, Kamenova M, Guzman R, Mariani L, Fandino J. Subperiosteal vs subdural drain after burr-hole drainage of chronic subdural hematoma: a randomized clinical trial (cSDH-drain-trial). Neurosurgery. 2019, 85:E825-34. 10.1093\/neuros\/nyz095","journal-title":"Neurosurgery"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-019-01249-4","article-title":"Comparison of total intravenous anesthesia vs. inhalational anesthesia on brain relaxation, intracranial pressure, and hemodynamics in patients with acute subdural hematoma undergoing emergency craniotomy: a randomized control trial","volume":"47","author":"Preethi J","year":"2021","unstructured":"Preethi J, Bidkar PU, Cherian A, Dey A, Srinivasan S, Adinarayanan S, Ramesh AS. Comparison of total intravenous anesthesia vs. inhalational anesthesia on brain relaxation, intracranial pressure, and hemodynamics in patients with acute subdural hematoma undergoing emergency craniotomy: a randomized control trial. Eur J Trauma Emerg Surg. 2021, 47:831-7. 10.1007\/s00068-019-01249-4","journal-title":"Eur J Trauma Emerg Surg"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-021-01334-w","article-title":"Hypothermia for patients requiring evacuation of subdural hematoma: a multicenter randomized clinical trial","volume":"36","author":"Hergenroeder GW","year":"2022","unstructured":"Hergenroeder GW, Yokobori S, Choi HA, et al.. Hypothermia for patients requiring evacuation of subdural hematoma: a multicenter randomized clinical trial. Neurocrit Care. 2022, 36:560-72. 10.1007\/s12028-021-01334-w","journal-title":"Neurocrit Care"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1022","article-title":"Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial","volume":"77","author":"Coutinho JM","year":"2020","unstructured":"Coutinho JM, Zuurbier SM, Bousser MG, et al.. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial. JAMA Neurol. 2020, 77:966-73. 10.1001\/jamaneurol.2020.1022","journal-title":"JAMA Neurol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2764","article-title":"Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial","volume":"76","author":"Ferro JM","year":"2019","unstructured":"Ferro JM, Coutinho JM, Dentali F, et al.. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol. 2019, 76:1457-65. 10.1001\/jamaneurol.2019.2764","journal-title":"JAMA Neurol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1177\/17474930211006303","article-title":"Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis","volume":"17","author":"Ferro JM","year":"2022","unstructured":"Ferro JM, Bendszus M, Jansen O, et al.. Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis. Int J Stroke. 2022, 17:189-97. 10.1177\/17474930211006303","journal-title":"Int J Stroke"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30181-2","article-title":"Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial","volume":"19","author":"Mohr J","year":"2020","unstructured":"Mohr J, Overbey J, Hartmann A, et al.. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020, 19:573-81. 10.1016\/S1474-4422(20)30181-2","journal-title":"Lancet Neurol"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006519","article-title":"The case against a randomized trial of unruptured brain arteriovenous malformations: misinterpretation of a flawed study","volume":"45","author":"Bambakidis NC","year":"2014","unstructured":"Bambakidis NC, Cockroft KM, Hirsch JA, Connolly ES, Amin-Hanjani S, Meyers PM, Friedlander RM. The case against a randomized trial of unruptured brain arteriovenous malformations: misinterpretation of a flawed study. Stroke. 2014, 45:2808-10. 10.1161\/STROKEAHA.114.006519","journal-title":"Stroke"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62302-8","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial","volume":"383","author":"Mohr JP","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C, et al.. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014, 383:614-21. 10.1016\/S0140-6736(13)62302-8","journal-title":"Lancet"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.666814","article-title":"Processed multiparameter electroencephalogram-guided general anesthesia management can reduce postoperative delirium following carotid endarterectomy: a randomized clinical trial","volume":"12","author":"Xu N","year":"2021","unstructured":"Xu N, Li LX, Wang TL, et al.. Processed multiparameter electroencephalogram-guided general anesthesia management can reduce postoperative delirium following carotid endarterectomy: a randomized clinical trial. Front Neurol. 2021, 12:666814. 10.3389\/fneur.2021.666814","journal-title":"Front Neurol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.10.066","article-title":"Anesthesia type determines risk of cerebral infarction after carotid endarterectomy","volume":"70","author":"Orlick\u00fd M","year":"2019","unstructured":"Orlick\u00fd M, Hrb\u00e1\u010d T, Same\u0161 M, et al.. Anesthesia type determines risk of cerebral infarction after carotid endarterectomy. J Vasc Surg. 2019, 70:138-47. 10.1016\/j.jvs.2018.10.066","journal-title":"J Vasc Surg"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.3310\/hta23410","article-title":"Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT","volume":"23","author":"Markus HS","year":"2019","unstructured":"Markus HS, Larsson SC, Dennis J, et al.. Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. Health Technol Assess. 2019, 23:1-30. 10.3310\/hta23410","journal-title":"Health Technol Assess"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.05.040","article-title":"Effects of dobutamine and phenylephrine on cerebral perfusion in patients undergoing cerebral bypass surgery: a randomised crossover trial","volume":"125","author":"Akkermans A","year":"2020","unstructured":"Akkermans A, van Waes JA, van Doormaal TP, et al.. Effects of dobutamine and phenylephrine on cerebral perfusion in patients undergoing cerebral bypass surgery: a randomised crossover trial. Br J Anaesth. 2020, 125:539-47. 10.1016\/j.bja.2020.05.040","journal-title":"Br J Anaesth"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.11.055","article-title":"Effect of sevoflurane Postconditioning on the incidence of symptomatic cerebral hyperperfusion after revascularization surgery in adult patients with Moyamoya disease","volume":"134","author":"Yoon HK","year":"2020","unstructured":"Yoon HK, Oh H, Lee HC, et al.. Effect of sevoflurane Postconditioning on the incidence of symptomatic cerebral hyperperfusion after revascularization surgery in adult patients with Moyamoya disease. World Neurosurg. 2020, 134:e991-e1000. 10.1016\/j.wneu.2019.11.055","journal-title":"World Neurosurg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162495-randomized-clinical-trials-in-cerebrovascular-neurosurgery-from-2018-to-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:31Z","timestamp":1707509551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162495-randomized-clinical-trials-in-cerebrovascular-neurosurgery-from-2018-to-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":116,"URL":"https:\/\/doi.org\/10.7759\/cureus.52397","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,16]]}}}